Skip to Content for Media Menu for Media About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

Media

Newsroom

The Media section provides reporters with easy access to Genentech information for stories in development. It also houses our recent and archived press releases.


Recent Press Releases

Nov 18, 2009
Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia

Nov 16, 2009
Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advanced Breast Cancer

Oct 17, 2009
Phase III Study Showed Two Years of ACTEMRA ® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission

Oct 17, 2009
Genentech and Biogen Idec Receive a Complete Response from FDA for Earlier Use of Rituxan for Rheumatoid Arthritis


MEDIA INQUIRIES

If you are a member of the media, please call our Corporate Relations department.

Corporate Relations: (650) 467-6800

SIGN UP FOR GENENTECH NEWS

Receive e-mail alert messages whenever a new press release is posted to this site.

FOLLOW GENENTECH ON TWITTER

Twitter LogoFollow Genentech on Twitter to receive the latest news and updates about the company.

NEWSROOM FEEDBACK

Please take a moment to fill out our .